Neovascular Glaucoma

06/01/2009 - "Intravitreal Bevacizumab injection produced regression of neovascularization and proved effective for treatment of neovascular glaucoma in this case of ocular ischemic syndrome."
01/01/2009 - "Bevacizumab appears to be effective in reducing iris and anterior chamber angle neovascularization and is likely to extend our therapeutic options in the management of neovascular glaucoma."
03/01/2006 - "Bevacizumab may be an effective medication for the treatment of neovascular glaucoma."
01/01/2007 - "Intravitreal bevacizumab was effective and safe in the short-term in a patient with neovascular glaucoma. "
01/01/2014 - "The aim of this study was to investigate the safety and efficacy of topically applied bevacizumab for the treatment of neovascular glaucoma (NVG). "

12/01/2002 - "This study aimed to investigate the safety and efficacy of trabeculectomy with intraoperative mitomycin C (MMC) in the management of eyes with neovascular glaucoma (NVG). "
05/01/2009 - "To evaluate the prognostic factors for surgical outcomes of trabeculectomy with mitomycin C (MMC) for neovascular glaucoma (NVG). "
05/01/2009 - "Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure."
01/01/2008 - "We sought to determine the effectiveness of trabeculectomy with mitomycin-C (MMC) in neovascular glaucoma (NVG) patients. "
10/01/2006 - "Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma."

03/01/2010 - "Anti-VEGF agents have been shown to be beneficial in treating neovascular glaucoma. "
11/01/2015 - "This study aimed to evaluate the angiogenesis-related factors of the vascular endothelial growth factor (VEGF) family in the aqueous humour of patients with neovascular glaucoma (NVG). "
12/01/2015 - "Vascular endothelial growth factor has been implicated as a key molecule in the development of newly formed vessels and neovascular glaucoma. "
11/01/2015 - "Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes."
07/01/2015 - "Aqueous concentrations of VEGF-A and PEDF were significantly elevated in eyes with neovascular glaucoma. "

02/01/2002 - "The prospective clinical interventional study included all 11 patients undergoing cyclocryocoagulation and/or retinal exocryocoagulation as treatment of neovascular glaucoma due to proliferate ischemic retinopathies. "
01/01/2014 - "Several retinal ischemic diseases can cause neovascular glaucoma (NVG). "
04/01/2013 - "Although a spectrum of serious complications resulting in total vision loss can occur, retention of useful vision is possible, in some cases, with aggressive treatment of the retinal lesions and associated neovascular glaucoma. "
04/01/2007 - "Isolated retinal venous occlusion rarely occurs in otherwise-healthy children.(1-3) We report a unilateral case of central retinal vein occlusion with secondary proliferative retinopathy and neovascular glaucoma in a 6-year-old girl. "
12/01/2001 - "The overall anatomical success rate of retinal attachment was 82.5% (199 eyes in 241 eyes), although it decreased to 45.1% (14 eyes in 31 eyes) in eyes with neovascular glaucoma. "

10/01/2013 - "Injection of 0.5 mg ranibizumab appears to be beneficial as an adjuvant treatment in neovascular glaucoma and rubeosis due to its anti-angiogenic properties and its ability to prevent establishment or progression of anterior chamber angle obstruction. "
10/01/2013 - "Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series."
06/01/2015 - "A Prospective Study to Evaluate Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma."
10/01/2013 - "Ten eyes with rubeosis (R) and ten eyes with neovascular glaucoma (NVG) received Lucentis injections (ranibizumab 0.5 mg/0.05 ml) in this prospective, monocenter, 12-months, interventional case series. "
10/01/2013 - "To evaluate the capability of adjuvant intraocular ranibizumab (Lucentis) injections in the treatment of rubeosis and intraocular pressure in patients with rubeosis and neovascular glaucoma. "

03/01/2000 - "Fluorescein fundus angiography and gonioangiography by fundus camera is very useful for diagnosis of neovascular glaucoma due to carotid artery occlusive disease. "
04/01/1994 - "Thus, fluorescein gonioangiography may be helpful in the diagnosis and clinical management of neovascular glaucoma."
11/01/1981 - "The results of a prospective clinical and fluorescein angiographic study of 155 patients with central retinal vein obstruction (CRVO) were analyzed to identify risk factors contributing to the subsequent development of iris neovascularization (NVI) and neovascular glaucoma (NVG). "
07/01/2011 - "Radiation retinopathy was suspected in 18% and confirmed by fluorescein angiography in 15%, ranging from mild to neovascular glaucoma/phthisis bulbi (2 eyes). "
09/01/2010 - "Secondary outcome was a composite of any adverse ocular outcome including: worsening of visual acuity, visual fields or fluorescein angiography, or development of iris neovascularization, any neovascularization or neovascular glaucoma. "

01/01/1980 - "Hence, Timolol treatment does not seem very effective in neovascular glaucoma, although it may be of some value as a supplement to surgical treatment, which is only indicated where the patient still has useful vision. "
01/01/1980 - "[Is timolol effective in neovascular glaucoma? "
01/01/1980 - "Timolol lowered intraocular pressure in six patients with severe neovascular glaucoma only from about 45 mmHg to about 38 mmHg. "
08/01/1987 - "Timolol, since it does not contribute significantly to hypoxia, may therefore be a more prudent choice for lowering intraocular pressure in disorders where hypoxia is believed to play an important role, such as in neovascular glaucoma and sickle-cell hyphema."
01/01/2015 - "To assess IOP-lowering efficacy of bimatoprost/timolol fixed combination (Ganfort®) in patients with diabetes mellitus (DM) and uncontrolled secondary neovascular glaucoma (NG). "

06/01/1995 - "There is a high risk of long-term failure of filtering surgery with 5-FU in neovascular glaucoma. "
06/01/1995 - "The long-term efficacy and safety of filtering surgery with 5-fluorouracil (5-FU) in eyes with neovascular glaucoma are unknown. "
06/01/1995 - "5-Fluorouracil filtering surgery and neovascular glaucoma. "
10/01/1992 - "We compared the effect of seton (White pump shunt) surgery (16 eyes) with that of trabeculectomy and 5-fluorouracil (31 eyes) in treating 38 Asian patients with medically uncontrollable neovascular glaucoma. "
01/01/2000 - "Needling with intra-bleb 5 fluorouracil for intractable neovascular glaucoma."

01/01/2001 - "[Neovascular glaucoma following proton-beam therapy. "
07/01/2013 - "Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation?"
07/01/2013 - "To evaluate the efficacy of endoresection after proton beam radiotherapy to prevent neovascular glaucoma (NVG) in patients treated for choroidal melanoma. "
10/01/2008 - "To report neovascular glaucoma after proton-beam radiotherapy of an adenocarcinoma of the pigmented ciliary epithelium and its successful treatment by iridocyclectomy. "
10/01/2008 - "Iridocyclectomy for neovascular glaucoma caused by proton-beam radiotherapy of pigmented ciliary adenocarcinoma."

11/01/2001 - "Despite systemic administration of urokinase and panretinal photocoagulation, neovascular glaucoma developed, and visual acuity diminished in both cases. "
08/01/1999 - "In both cases, systemic steroid therapy gradually improved the retinal vasculitis, but central retinal vein occlusions gradually developed, and in spite of systemic administration of urokinase and panretinal photocoagulation, neovascular glaucoma developed, and visual acuity became degraded in both cases. "

03/01/2009 - "The purpose of the study was to evaluate the long-term efficacy of contact transscleral cyclophotocoagulation (TSCPC) performed after panretinal photocoagulation and cryoapplication in patients with angle closure neovascular glaucoma. "
04/01/2013 - "However, VT and panretinal photocoagulation improved visual acuity and reduced the incidence of neovascular glaucoma in CRVO with VH."
07/01/1982 - "Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction."
11/01/2014 - "The ciliary epithelium may represent an additional focus of treatment in the management of neovascular glaucoma, especially in eyes that are nonresponsive to panretinal photocoagulation."
01/01/2012 - "To prevent neovascular glaucoma, intense prophylactic panretinal photocoagulation was initiated 2 weeks later. "

09/01/1988 - "The visual acuities remained within one line of their preoperative levels or improved in 31 (76%) of the 41 aphakic or pseudophakic eyes with non-neovascular glaucomas; 3 (30%) of the 10 phakic eyes with non-neovascular glaucomas after failed filtering surgery; 10 (67%) of the 15 eyes with neovascular glaucomas; and 9 (100%) of the 9 eyes with non-neovascular glaucomas in patients younger than 13 years of age on whom Snellen acuity was available.(ABSTRACT TRUNCATED AT 250 WORDS)"
12/01/1986 - "The visual acuities remained within one line of their preoperative levels or improved in 38 (79%) of the 48 aphakic eyes with non-neovascular glaucoma, 11 (69%) of the 16 phakic eyes with non-neovascular glaucoma after unsuccessful filtering surgery, and 12 (75%) of the 16 eyes with NVG. "
05/01/2009 - "[Antiangiogenic treatment for neovascular glaucoma and after filtering surgery]."
01/01/1996 - "Long-term results of Krupin-Denver valve implants in filtering surgery for neovascular glaucoma."
09/01/1988 - "Postoperative IOP was less than 21 mmHg in 77% of eyes with neovascular glaucoma (47% required additional medication) and in 82% of eyes with previous failure of filtration surgery (56% required additional medication)."

04/01/2015 - "The aim of this study was to investigate the expression of uncoupling protein 2 (UCP2) and zonula occludens-1 (ZO-1) in the trabecular meshwork (TM) of neovascular glaucoma (NVG) patients treated with trabeculectomy. "
10/01/1977 - "A clinicopathologic study was performed of a scleral staphyloma occurring two years after a trabeculectomy for neovascular glaucoma. "
01/01/2013 - "Hispanic ethnicity, neovascular glaucoma, previous trabeculectomy, and combined surgery were identified as potential risk factors for tube shunt exposure. "
01/01/2013 - "Risk factors associated with tube exposure were Hispanic ethnicity (P = 0.0115; OR = 3.6; 95% CI, 1.3-9.7), neovascular glaucoma (P = 0.0064; OR = 28.5; 95% CI, 2.6-316.9), previous trabeculectomy (P = 0.0070; OR = 5.3; 95% CI, 1.6-17.7), and combined surgery (P = 0.0381; OR = 3.7; 95% CI, 1.1-12.7). "
05/01/2011 - "An augmented trabeculectomy for neovascular glaucoma."

01/01/1983 - "This study showed a statistically significant increase in the postoperative incidence of neovascular glaucoma in eyes undergoing combined lensectomy and vitrectomy compared to eyes in which the lens was not removed."
01/01/2015 - "To describe characteristics and outcomes of combined pars plana vitrectomy and Baerveldt tube insertion procedure from 2005 to 2010 in eyes with neovascular glaucoma. "
01/01/2015 - "Combined pars plana vitrectomy and pars plana Baerveldt tube placement in eyes with neovascular glaucoma."
05/01/2013 - "ECP can be effectively combined with vitrectomy; however, ECP produced unpredictable results in the two patients with neovascular glaucoma."
07/01/2007 - "Pars plana vitrectomy and Ahmed valve implantation seems to be a viable surgical modality in the management of neovascular glaucoma and coexisting posterior segment pathology with a relatively low rate of serious permanent postoperative complications."

08/01/2009 - "To study the safety and efficacy of intravitreal injection of bevacizumab followed by aqueous shunting tube surgery for the management of neovascular glaucoma (NVG). "
01/01/2007 - "To assess the short-term safety and efficacy of an intravitreal injection of bevacizumab in a patient with neovascular glaucoma. "
07/01/2012 - "To investigate the clinical and electrophysiologic effect of a single intravitreal injection of bevacizumab for neovascular glaucoma (NVG) after ischemic central retinal vein occlusion (iCRVO). "
04/01/2009 - "Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab."
02/01/2009 - "Intravitreal injection of 1.25 mg (0.05 ml) of bevacizumab contributes to a better management of neovascular glaucoma."